论文部分内容阅读
我院儿科于1994年1月至1997年12月采用博利康尼加息斯敏治疗小儿咳嗽变异性哮喘(Cough vanent asthma,CVA)64例,取得满意疗效,报道如下。 1 临床资料 1.1 诊断标准 全部病例均符合CVA诊断标准:①咳嗽或反复发作>1个月,常于夜间或清晨发作性咳嗽,痰少;②临床无感染征象或经较长期抗菌药治疗无效;③单用平喘药可使咳嗽发作缓解(基本诊断条件);④有个人过敏史或家族过敏史。1.2 一般资料 ①性别:男34例,女30例;②年龄:～1岁12例,～3岁22例,～6岁18例,～14岁12例,最小6个月,最大14周岁;③发病季节:12～2月19例,3～5月20例,6～8月15例,9～11月10例;④病程:最短1个月,最长8个月。
In our pediatric department from January 1994 to December 1997, 64 cases of pediatric cough variant asthma (Cough vanent asthma, CVA) were treated with Boli Kang Ni Jia Min Si Min, and achieved satisfactory results, the report is as follows. 1 Clinical data 1.1 diagnostic criteria All cases are in line with CVA diagnostic criteria: ① cough or recurrent> 1 month, often in the night or early morning episodes of cough, sputum less; ② no signs of clinical infection or longer-term antimicrobial treatment ineffective; ③ asthma alone can relieve cough attack (basic diagnostic conditions); ④ personal allergies or family history of allergy. 1.2 General information ① gender: 34 males and 30 females; ② age: 12 cases of ~ 1 year old, 22 cases of ~ 3 years old, 18 cases of ~ 6 years old, 12 cases of ~ 14 years old, a minimum of 6 months and a maximum of 14 years; ③ onset season: 12 cases in February to February, 20 cases in March to May, June to August in 15 cases, 9 to November in 10 cases; ④ course of disease: the shortest 1 month, up to 8 months.